By Dr. Joey Grice
Summary: MTHFR gets most of the attention, but the methylation cycle also depends on vitamin B12 and two partner genes, MTR and MTRR. Here's what peer-reviewed research shows about those genes, the different forms of B12, and everyday factors that can lower B12 status—plus the limits of each study.
Where B12 Fits in the Methylation Cycle
Every day your cells recycle homocysteine back into methionine, the building block for SAMe, your body's main methyl donor. The enzyme that does this step is methionine synthase, made from the MTR gene. It needs two partners: methylfolate (the folate form MTHFR helps produce) and vitamin B12 in its active form, methylcobalamin.
Over time, the B12 inside methionine synthase can "wear out." A second enzyme, methionine synthase reductase, made from the MTRR gene, helps restore it so the cycle keeps turning.
What One MTRR Study Found
In 2001, Gaughan and colleagues studied 601 men aged 30 to 49 in Northern Ireland. They found that a common MTRR gene variation (A66G) had a significant influence on blood homocysteine. Men with the 66AA genotype had a moderately higher chance of being in the upper half of homocysteine levels, and this effect did not depend on their folate, B12, or B6 levels.
Limitations: this was a single observational study in middle-aged men, and the effect was modest. Interestingly, the genotype linked with higher homocysteine here was AA, not the G version often labeled the "variant"—a good reminder that single gene results need careful interpretation. A genotype describes a tendency, not a diagnosis.
Does the Form of B12 Matter?
Supplements usually contain cyanocobalamin, hydroxocobalamin, methylcobalamin, or adenosylcobalamin. Many people assume the "methyl" form is always better. A 2015 review by Obeid, Fedosov, and Nexo looked closely at how cells process each form. Inside the cell, all of them are converted to the same core form and then rebuilt into the two active coenzymes. The authors concluded that methylcobalamin or adenosylcobalamin is unlikely to have an advantage over cyanocobalamin for preventing or correcting low B12 in general.
Limitations: this is a review of biochemistry and existing evidence, not a new head-to-head trial, and research on individual genetic differences is still limited.
Everyday Factors That Can Lower B12
Genes are only part of the story. Some common medications are linked with lower B12:
Metformin: In a randomized, placebo-controlled trial of 390 people with type 2 diabetes using insulin, de Jager and colleagues found that 4.3 years of metformin lowered B12 by an average of 19% compared with placebo. The absolute risk of B12 deficiency was 7.2 percentage points higher. People with deficient B12 at the end of the trial had higher homocysteine.
Acid-reducing medications: In a large Kaiser Permanente study, Lam and colleagues compared 25,956 people diagnosed with B12 deficiency with 184,199 people without it. Two or more years' supply of proton pump inhibitors was linked with higher odds of deficiency (odds ratio 1.65), and H2 blockers with a smaller increase (1.25).
Limitations: the metformin trial studied a specific group with diabetes. The Lam study was observational, so it shows an association, not proof of cause. Never stop or change a prescription on your own—talk with your prescriber, who may simply check your B12 levels.
The Takeaway
B12 status depends on genes like MTR and MTRR, on diet, on absorption, and on the medications you take. Nutrition and supplements don't change your genes, but the right nutrients may support how the methylation pathway works.
Explore Your Genetic Wellness Plan
Curious how your methylation genes and lifestyle fit together? Schedule a genetic wellness consultation with Genetic Wellness Group at our Mars, PA, or Mt. Washington (Pittsburgh) office. Visit geneticwg.com/contact to get started.
This article is for educational purposes only and is not a substitute for personalized advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk with your healthcare provider before starting or changing any supplement, especially if you are pregnant, nursing, taking medications, or managing a condition.
References
Gaughan DJ, Kluijtmans LA, Barbaux S, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis. 2001;157(2):451-456. https://pubmed.ncbi.nlm.nih.gov/11472746/
Obeid R, Fedosov SN, Nexo E. Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency. Mol Nutr Food Res. 2015;59(7):1364-1372. https://pubmed.ncbi.nlm.nih.gov/25820384/
de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181. https://pubmed.ncbi.nlm.nih.gov/20488910/
Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-2442. https://pubmed.ncbi.nlm.nih.gov/24327038/